Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit.

BACKGROUND Surface-active antiseptics, such as chlorhexidine, are increasingly being used as part of intervention programs to prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission, despite limited evidence and potential for resistance. We report on the effect of an antiseptic protocol on acquisition of both endemic MRSA and an outbreak strain of MRSA sequence type 239 (designated TW). METHODS Interrupted time-series data on MRSA acquisitions in two 15-bed intensive care units were analyzed using segmented regression models to estimate the effects of sequential introduction of an educational campaign, cohorting, and a chlorhexidine-based antiseptic protocol on transmission of TW and non-TW MRSA strains. Representative TW and non-TW MRSA strains were assessed for carriage of qacA/B genes and antiseptic susceptibility. RESULTS The antiseptic protocol was associated with a highly significant, immediate 70% reduction in acquisition of non-TW MRSA strains (estimated model-averaged incidence rate ratio, 0.3; 95% confidence interval, 0.19-0.47) and an increase in acquisition of TW MRSA strains (estimated model-averaged incidence rate ratio, 3.85; 95% confidence interval, 0.80-18.59). There was only weak evidence of an effect of other interventions on MRSA transmission. All TW MRSA strains (21 of 21 isolates) and <5% (1 of 21 isolates) of non-TW MRSA strains tested carried the chlorhexidine resistance loci qacA/B. In vitro chlorhexidine minimum bactericidal concentrations of TW strains were 3-fold higher than those of non-TW MRSA strains, and in vivo, only patients with non-TW MRSA demonstrated a reduction in the number of colonization sites in response to chlorhexidine treatment. CONCLUSION A chlorhexidine-based surface antiseptic protocol can interrupt transmission of MRSA in the intensive care unit, but strains carrying qacA/B genes may be unaffected or potentially spread more rapidly.

[1]  Steve Shaw,et al.  Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two centre study , 2005, The Lancet.

[2]  F. Sarubbi,et al.  Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus: Does Mupirocin Remain Effective? , 2003, Infection Control &#x0026; Hospital Epidemiology.

[3]  Marc J M Bonten,et al.  Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  E. Wong,et al.  Selective Use of Intranasal Mupirocin and Chlorhexidine Bathing and the Incidence of Methicillin-Resistant Staphylococcus aureus Colonization and Infection Among Intensive Care Unit Patients , 2007, Infection Control & Hospital Epidemiology.

[5]  M. Jackson,et al.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings , 2007, American Journal of Infection Control.

[6]  A. Holck,et al.  Frequency of Disinfectant Resistance Genes and Genetic Linkage with β-Lactamase Transposon Tn552 among Clinical Staphylococci , 2002, Antimicrobial Agents and Chemotherapy.

[7]  Yee-Chun Chen,et al.  Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. , 2008, The Journal of antimicrobial chemotherapy.

[8]  R. Wenzel,et al.  Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. , 2008, The Cochrane database of systematic reviews.

[9]  A. Kiss,et al.  Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Adrian E. Raftery,et al.  Bayesian model averaging: a tutorial (with comments by M. Clyde, David Draper and E. I. George, and a rejoinder by the authors , 1999 .

[11]  Adrian G. Barnett,et al.  Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. , 2009, American journal of epidemiology.

[12]  A. M. Sandri,et al.  Reduction in Inddence of Nosocomial Methicillin-Resistant Staphylococcus aureus (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA , 2006, Infection Control &#x0026; Hospital Epidemiology.

[13]  J. Edgeworth,et al.  Throat and rectal swabs may have an important role in MRSA screening of critically ill patients , 2008, Intensive Care Medicine.

[14]  C. Ramsay,et al.  Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. , 2003, The Journal of antimicrobial chemotherapy.

[15]  R. Beale,et al.  An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Austin,et al.  Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. , 2002, The Journal of infectious diseases.

[17]  B. Campillo,et al.  A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit. , 2002, The Journal of hospital infection.

[18]  I. Hudson,et al.  The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. , 1994, The Journal of hospital infection.

[19]  C. Watanakunakorn,et al.  Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. , 1995, American journal of infection control.

[20]  J. Edgeworth,et al.  Rapid determination of hospital-acquired meticillin-resistant Staphylococcus aureus lineages. , 2007, Journal of medical microbiology.

[21]  H. Humphreys,et al.  Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. , 2006, The Journal of hospital infection.

[22]  S. Amyes,et al.  Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates. , 2008, The Journal of antimicrobial chemotherapy.

[23]  I. Paulsen,et al.  Bioenergetics of the Staphylococcal Multidrug Export Protein QacA , 1999, The Journal of Biological Chemistry.

[24]  Stephan Harbarth,et al.  Randomized, Placebo-Controlled, Double-Blind Trial To Evaluate the Efficacy of Mupirocin for Eradicating Carriage of Methicillin-Resistant Staphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.

[25]  B. Cookson,et al.  Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment , 1991, Antimicrobial Agents and Chemotherapy.

[26]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[27]  R A Weinstein,et al.  Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  D. Anderson,et al.  Value of Whole-Body Washing With Chlorhexidine for the Eradication of Methicillin-Resistant Staphylococcus aureus: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial , 2007, Infection Control &#x0026; Hospital Epidemiology.

[29]  C. Brun-Buisson,et al.  Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  William E Trick,et al.  Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. , 2006, Archives of internal medicine.

[31]  H. Loveday,et al.  A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). , 2006, The Journal of hospital infection.

[32]  H. Humphreys,et al.  Erratum to “Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities [Journal of Hospital Infection 2006;63:S1–S44]” , 2006 .

[33]  T. Perl,et al.  Chlorhexidine: expanding the armamentarium for infection control and prevention. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  F. Schmitz,et al.  Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.

[35]  J M Robins,et al.  The role of model selection in causal inference from nonexperimental data. , 1986, American journal of epidemiology.

[36]  G. MacLennan,et al.  Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit. , 2007, International journal of antimicrobial agents.

[37]  M. Jackson,et al.  Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.

[38]  Helen Burstin,et al.  Strategies to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus in Acute Care Hospitals , 2008, Infection Control &#x0026; Hospital Epidemiology.

[39]  I. Hunter,et al.  The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. , 2007, The Journal of antimicrobial chemotherapy.